Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Adaptive Therapy for Post-Second-Line Advanced Breast Cancer [Phase 2]
Phase 2 trial evaluating adaptive therapy for post-second-line HER2-negative metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment [Phase 2]
Phase 2 trial of eribulin monotherapy as first-line treatment for HER2-negative metastatic breast cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer [Phase 1]
Phase 1 trial evaluating whether combining a ketogenic diet with chemotherapy can affect recurrence in patients with stage IV breast cancer;…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Myofascial Massage for Pain and Immobility Following Breast Cancer Surgery [NA]
The clinical trial evaluating myofascial massage for pain, shoulder mobility, and lymphedema after breast cancer surgery has completed. The …
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery [Phase 3]
Phase 3 trial comparing hippocampus-sparing whole-brain radiotherapy to stereotactic radiosurgery for patients with brain metastases from va…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer [Phase 1]
This Phase 1 trial evaluates safety, tolerability, pharmacokinetics, and preliminary efficacy of BTX-9341 in advanced or metastatic breast c…
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: The Use of AI to Safely Reduce the Workload in Breast Cancer Screening With Mammography in Region Östergötland
A completed study evaluating AI-assisted mammography to safely reduce radiologist workload in breast cancer screening in Östergötland.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: Tucatinib Together With Pembrolizumab and Trastuzumab [Phase 2]
APhase 2 trial evaluating tucatinib in combination with pembrolizumab and trastuzumab for HER2-positive breast cancer was terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-06Clinical Trial Update: 3D-printed Biodegradable Breast Implants for Breast Restoration [Phase 2]
Phase 2 clinical trial update evaluating 3D-printed biodegradable breast implants for breast restoration in breast cancer patients; recruitm…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Doxil/Caelyx BE Study [Phase 1]
Phase 1 bioequivalence study completion for Doxil/Caelyx in ovarian cancer, Kaposi sarcoma, multiple myeloma, and metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Interventions to Decrease Financial Toxicity [NA]
A completed clinical trial evaluating interventions to reduce financial toxicity in cancer care. The study was sponsored by the University o…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: A Mind-Body Intervention for Hot Flash Management [NA]
A completed clinical trial evaluated a mind-body intervention for hot flashes and postmenopausal symptoms, with results posted on 2025-06-05…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity [Phase 1]
A Phase I trial evaluating the safety and immune response of a xenogeneic HER2/Neu DNA vaccine in patients with metastatic or high-risk brea…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors [Phase 3]
A Phase 3 trial evaluating Faslodex with or without concomitant Arimidex versus Exemestane after progression on non-steroidal aromatase inhi…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: PG2 Treatment Among Stage II/III Breast Cancer Patients Receiving Adjuvant Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating PG2 in stage II/III breast cancer patients receiving adjuvant chemotherapy has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Sulindac and Breast Density in Women at Risk of Developing Breast Cancer [Phase 2]
Phase 2 clinical trial evaluating sulindac for changes in breast density in women at risk of developing breast cancer; the study has complet…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Advanced Diffusion Tensor MRI for Breast Cancer
A clinical trial evaluating advanced diffusion tensor MRI for breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Pembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor Progression [Phase 2]
A phase 2 trial of pembrolizumab plus paclitaxel in HR+/HER2- non-luminal advanced/metastatic breast cancer after CDK4/6 inhibitor progressi…
-
CLINICAL_TRIALS trial_result · 2025-06-02Clinical Trial Update: Comparison Between IORT and Postoperative Radiotherapy in Breast Conserving Surgery [NA]
A clinical trial comparing intraoperative radiotherapy (IORT) with postoperative radiotherapy in breast-conserving surgery has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer [Phase 2]
A Phase 2 trial evaluating a circulating tumor DNA–enriched, genomically directed post-neoadjuvant approach for patients with residual tripl…
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Ribociclib + PDR001 in Breast Cancer and Ovarian Cancer [Phase 1]
A Phase 1 trial evaluating ribociclib in combination with PDR001 for metastatic hormone-receptor-positive (HR+) breast cancer, HER2-negative…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC [Phase 2]
A Phase 2 clinical trial update reports results for sacituzumab govitecan with or without pembrolizumab in HR-positive, HER2-negative metast…
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Chemotherapy-induced Lipid Profile Changes in Women With Early Breast Cancer
A completed clinical trial assessing chemotherapy-induced changes in lipid profiles among women with early breast cancer.
-
CLINICAL_TRIALS trial_result · 2025-05-30Clinical Trial Update: Randomized Phase III Trial With Mepitel Film for the Prophylaxis of Radiation Dermatitis in Breast Cancer Patients [NA]
A randomized phase III trial is evaluating Mepitel Film to prophylax against radiation dermatitis in breast cancer patients. The study is sp…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Pembrolizumab in Combination With Olaparib in Advanced BRCA-mutated or HDR-defect Breast Cancer [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with olaparib for advanced BRCA-mutated or homologous recombination deficiency breast …